Partner Resources
Medlive CME: Immunotherapy in Non-Melanoma Skin Cancers
Have We Just Scratched the Surface of BCC and cSCC?
Stay current on emerging data and best practices for integrating immune checkpoint inhibitors (ICIs) into treatment plans for BCC and cSCC. Learn how to optimize perioperative strategies, assess patient eligibility for neoadjuvant immunotherapy, and coordinate multidisciplinary care to improve outcomes.
Dermatology Times
The Skin Cancer Foundation is a Dermatology Times Strategic Alliance Partner. We collaborate on editorial content for the Dermatology Times website and coordinate media opportunities for the Foundation’s member physicians.
If you are interested in attending a Dermatology Times event and wish to be notified when they are hosting one in your area or disease specialty, join the Dermatology Times Guest List to be one of the first to receive exclusive information.
- June 9, Tampa Florida — Topic: Advancing Multidisciplinary Care in Cutaneous Squamous Cell Carcinoma. Details and registration here.
- June 11; Charleston, S.C. — Topic: Real-World Management of CSCC: Expert Approaches to Complex Cases. Details and registration here.
- June 17; Miami, Forida — Topic: Advancing Multidisciplinary Care in Cutaneous Squamous Cell Carcinoma. Details and registration here.
- June 23; Dallas, Texas — Topic: Advancing Multidisciplinary Care in Cutaneous Squamous Cell Carcinoma. Details and registration here.
- June 24; Nashville, Tenn.— Topics: Immunotherapy for Locally Advanced Skin Cancer & Real-World Management of CSCC: Expert Approaches to Complex Cases. Details and Registration here.